Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-16-600785
Filing Date
2016-05-24
Accepted
2016-05-24 17:24:06
Documents
8
Period of Report
2016-07-14

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d175958dpre14a.htm PRE 14A 563592
2 GRAPHIC g175958pc1.jpg GRAPHIC 141000
3 GRAPHIC g175958pc2.jpg GRAPHIC 100216
4 GRAPHIC g175958txpg001a.jpg GRAPHIC 4352
5 GRAPHIC g175958txpg001b.jpg GRAPHIC 2557
6 GRAPHIC g175958txpg004a.jpg GRAPHIC 1716
7 GRAPHIC g175958txpg004b.jpg GRAPHIC 1043
8 GRAPHIC g175958txpg004c.jpg GRAPHIC 1266
  Complete submission text file 0001193125-16-600785.txt   912959
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33958 | Film No.: 161672766
SIC: 2834 Pharmaceutical Preparations